DPIV/CD26 and FAP in Cancer: A Tale of Contradictions

  • Conference paper
Dipeptidyl Aminopeptidases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
GBP 19.95
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
GBP 143.50
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
GBP 179.99
Price includes VAT (United Kingdom)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
GBP 179.99
Price includes VAT (United Kingdom)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbott CA and Gorrell MD. (2002) In Ectopeptidases: CD13/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology, (Eds, Langner, J. and Ansorge, S.) Kluwer/Plenum, New York, pp. 171–195.

    Google Scholar 

  • Abbott CA, McCaughan GW, Levy MT, Church WB and Gorrell MD. (1999) Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlap**, discontinuous sites on a predicted beta propeller domain. Eur J Biochem. 266: 798–810.

    Article  CAS  PubMed  Google Scholar 

  • Adams S, Miller GT, Jesson MI, Watanabe T, Jones B and Wallner BP. (2004) PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 64: 5471–80.

    Article  CAS  PubMed  Google Scholar 

  • Ajami K, Abbott CA, Obradovic M, Gysbers V, Kähne T, McCaughan GW and Gorrell MD. (2003) Structural requirements for catalysis, expression and dimerisation in the CD26/DPPIV gene family. Biochemistry USA. 42: 694–701.

    Article  CAS  Google Scholar 

  • Asada Y, Aratake Y, Kotani T, Marutsuka K, Araki Y, Ohtaki S and Sumiyoshi A, 1993, Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathol. 23: 265–270.

    CAS  Google Scholar 

  • Bogenrieder T, Finstad CL, Freeman RH, Papandreou CN, Scher HI, Albino AP, Reuter VE and Nanus DM, 1997, Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate. 33: 225–232.

    Article  CAS  PubMed  Google Scholar 

  • Cheng HC, Abdel-Ghany M and Pauli BU, 2003, A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem. 278: 24600–24607.

    Article  CAS  PubMed  Google Scholar 

  • Cheng JD, Valianou M, Canutescu A, Jaffe EK, Lee H-O, Wang H, Lai JH, Bachovchin WW and Weiner LM, 2005, Abrogation of fibroblast activation protein enzymatic activity attenuates tumour growth. Mol Canc Therap. 4: 351–360.

    CAS  Google Scholar 

  • Cordero OJ, Ayude D, Nogueira M, Rodriguez-Berrocal FJ and de la Cadena MP, 2000, Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer. 83: 1139–1146.

    Article  CAS  PubMed  Google Scholar 

  • de la Haba-Rodriguez J, Macho A, Calzado MA, Blazquez MV, Gomez MA, Munoz EE and Aranda E, 2002, Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. Neoplasma. 49: 307–311.

    PubMed  Google Scholar 

  • Ghersi G, Chen W, Lee EW and Zukowska Z, 2001, Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides. 22: 453–458.

    Article  CAS  PubMed  Google Scholar 

  • Ghersi G, Dong H, Goldstein LA, Yeh Y, Hakkinen L, Larjava HS and Chen WT, 2002, Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem. 277: 29231–29241.

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Gronow M, Grenett HE, Gawdi G and Pizzo SV, 2005, Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26. Exp Cell Res. 303: 22–31.

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Gronow M, Grenett HE, Weber MR, Gawdi G and Pizzo SV, 2001, Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem J. 355: 397–407.

    Article  CAS  PubMed  Google Scholar 

  • Goodman JD, Rozypal TL and Kelly T, 2003, Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells. Clin Exp Metastasis. 20: 459–470.

    Article  CAS  PubMed  Google Scholar 

  • Hoffman T, von Horsten S, Hama Y, Shingu K, Demuth H-U and Heiser U, 2003, Chronic Treatment with Dipeptidyl Peptidase IV (DPIV) inhibitors inhibits tumour metastasis in the MADB106 Adenocarcinoma rat model, In 3rd General Meeting of the International Proteolysis Society. Japan 2003.

    Google Scholar 

  • Houghton AN, Albino AP, Cordon-Cardo C, Davis LJ and Eisinger M, 1988, Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J Exp Med. 167: 197–212.

    Article  CAS  PubMed  Google Scholar 

  • Huang Y, Wang S and Kelly T, 2004, Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 64: 2712–2716.

    Article  CAS  PubMed  Google Scholar 

  • Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU and Garin-Chesa P, 2003, Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol. 120: 182–188.

    Article  CAS  PubMed  Google Scholar 

  • Iwata S and Morimoto C, 1999, CD26/dipeptidyl peptidase IV in context: the different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med. 190: 301–305.

    Article  CAS  PubMed  Google Scholar 

  • Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K and Mizutani S, 2003, Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 63: 2278–2283.

    CAS  PubMed  Google Scholar 

  • Kajiyama H, Kikkawa F, Maeda O, Suzuki T, Ino K and Mizutani S, 2002a, Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients. Oncology. 63: 158–165.

    Article  CAS  PubMed  Google Scholar 

  • Kajiyama H, Kikkawa F, Suzuki T, Shibata K, Ino K and Mizutani S, 2002b, Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res. 62: 2753–2757.

    CAS  PubMed  Google Scholar 

  • Kikkawa F, Kajiyama H, Ino K, Shibata K and Mizutani S, 2003, Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV. Int J Cancer. 105: 779–783.

    Article  CAS  PubMed  Google Scholar 

  • Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz K-N, Leung E, Baraldi PG and Borea A, 2002, Adenosine Receptors as Mediators of Both Cell Proliferation and Cell Death of Clutured Human Melanoma Cells. J Invest Dermatol. 119: 923–933.

    Article  CAS  PubMed  Google Scholar 

  • Mueller SC, Ghersi G, Akiyama SK, Sang QXA, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y and Chen WT, 1999, A novel protease-docking function of integrin at invadopodia. J Biol Chem. 274: 24947–24952.

    Article  CAS  PubMed  Google Scholar 

  • Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E and Zlotnik A, 2001, Involvement of chemokine receptors in breast cancer metastasis. Nature. 410: 50–56.

    Article  CAS  PubMed  Google Scholar 

  • Pethiyagoda C, Welch D and Fleming T. (2001) Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis. 18: 391–400.

    Article  Google Scholar 

  • Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P and Houghton AN, 2004, FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 23: 5435–5446.

    Article  CAS  PubMed  Google Scholar 

  • Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP and Old LJ, 1993, Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 53: 3327–3335.

    CAS  PubMed  Google Scholar 

  • Tan EY, Mujoomdar M and Blay J, 2004, Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior. Am J Pathol. 165: 319–330.

    CAS  PubMed  Google Scholar 

  • Wesley UV, Albino AP, Tiwari S and Houghton AN, 1999, A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 190: 311–322.

    Article  CAS  PubMed  Google Scholar 

  • Wesley UV, McGroarty M and Homoyouni A, 2005, Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 65: 1325–1334.

    Article  CAS  PubMed  Google Scholar 

  • Wesley UV, Tiwari S and Houghton AN, 2004, Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Canc. 109: 855–866.

    Article  CAS  Google Scholar 

  • Yan L, Shahied L, Tang Y, Kesavan P and Nakada T, 2004, Tumor-Host Interactions. Preclinica. 2: 422–426.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Sulda, M.L., Abbott, C.A., Hildebrandt, M. (2006). DPIV/CD26 and FAP in Cancer: A Tale of Contradictions. In: Lendeckel, U., Reinhold, D., Bank, U. (eds) Dipeptidyl Aminopeptidases. Advances in Experimental Medicine and Biology, vol 575. Springer, Boston, MA . https://doi.org/10.1007/0-387-32824-6_21

Download citation

Publish with us

Policies and ethics

Navigation